INSY

Insys Therapeutics, Inc. News Headlines

$38.81
*  
0.22
0.56%
Get INSY Alerts
*Delayed - data as of Oct. 21, 2014  -  Find a broker to begin trading INSY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    INSY After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Baxter Meets Earnings, Misses Revs - Analyst Blog
10/17/2013 11:04:01 AM - Zacks.com


ATHN Unit Unveils New Mobile App - Analyst Blog
10/16/2013 5:46:58 PM - Zacks.com


Heritage Valley Implements MDRX Sunrise - Analyst Blog
10/16/2013 3:47:00 PM - Zacks.com


St. Jude Buys Pacemaker Manufacturer - Analyst Blog
10/15/2013 4:20:01 PM - Zacks.com


Cramer's Mad Money - FDA Roulette (10/10/13)
10/11/2013 6:52:00 AM - Seeking Alpha


Cramer's Lightning Round - Biotechs And High Flyers Are For Sale (10/9/13)
10/10/2013 3:09:00 AM - Seeking Alpha


INSYS Therapeutics (INSY) in Focus: Stock Gains 11.2% - Analyst Blog
10/8/2013 8:44:47 AM - Zacks.com


A Fresh Look At The U.S. Medical Marijuana Market
9/12/2013 12:20:00 PM - Seeking Alpha


Insys Therapeutics: A Profitable Pharmaceutical Company With Great Potential Growth
8/14/2013 4:49:00 PM - Seeking Alpha


Company News for August 14, 2013 - Corporate Summary
8/14/2013 9:56:30 AM - Zacks.com


3 Healthcare Companies With Recent Intensive Insider Buying
6/9/2013 8:17:00 AM - Seeking Alpha


Kamada, Epizyme Close out Huge Month for IPOs
5/31/2013 3:54:00 PM - Wyatt Investment Research


IPOs on Pace for Record Month
5/13/2013 10:41:01 AM - Wyatt Investment Research


U.S. IPO Recap: Activity Remains Robust With 5 Pricings, 5 Setting Terms And 4 New Filers
5/6/2013 11:32:00 AM - Seeking Alpha


Insys Therapeutics prices IPO at $8, at the low end of the revised range
5/2/2013 9:32:48 AM - Renaissance Capital


Insys Therapeutics decreases range, now plans to raise $36 million
5/2/2013 8:43:02 AM - Renaissance Capital


IPO Preview: Insys Therapeutics
5/2/2013 12:21:00 AM - Seeking Alpha


6 US IPOs planned for the week of Apr 29
4/29/2013 8:00:02 AM - Renaissance Capital


Insys Therapeutics sets terms for $68 million IPO
4/19/2013 4:50:13 PM - Renaissance Capital


Five Biotech Stocks Worth Watching
11/29/2010 2:05:00 PM - Seeking Alpha